Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-16
1999-12-14
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
060018615
ABSTRACT:
The present invention provides the use of pramipexole in the treatment of restless legs syndrome.
REFERENCES:
patent: 5112842 (1992-05-01), Zierenberg et al.
JE Ahlskog, et al., "Adjunctive Cabergoline Therapy of Parkinson's Disease: Comparison with Placebo and Assessment of Dose Response and Duration of Effect," Clin. Neuropharmacol, 1996; 19:202-212.
S Akpinar, "Restless Legs Syndrome Treatment with Dopaminergic Drugs," Clinical Neuropharmacology, 1987; 10:69-79.
RP Allen, et al., "Augmentation of the Restless Legs Syndrome with Carbidopa/Levodopa" Sleep, 1996; 19(3):205-13.
Anonymous Author, "My Doctor Prescribed Sinemet for my Restless Legs and it was a Catastrophe." Johns Hopkins Medical Letter, Health After 50, 1998; 10 (12) 8.
Anonymous Author, "Restless Legs Syndrome Often Not Recognized, May be Misdiagnosed," Geriatrics, 1998; 53(2): 101.
PM Becker, et al., "Dopaminergic Agents in Restless Legs Syndrome and Periodic Limb Movements of Sleep: Response and Complications of Extended Treatment in 49 Cases," 1993; Sleep, 16(8); pp. 713-716.
D Boghen, et. al., "The Treatment of Restless legs Syndrome with Clonazepam: A Prospective Controlled Study," Can J Neurol Sci, 1986; 13:245-247.
B Bornstein, "Restless Legs," Psychiat Neurol, 1961; 141:165-201.1.
C Brodeur, et. al., "Treatment of RLS and PMS with L-dopa: A Double-blind Controlled Study," Neurology, 1988, 35:1845-1848.
N Callaghan, "Restless Legs Syndrome in uremic Neuropathy," Neurology, 1966; 16:359-361.
RM Coleman, "Periodic Movements in Sleep (Nocturnal Myoclonus) and Restless Legs Syndrome." In: Guilleminault C, (ed) Sleeping and Walking Disorders: Indications and Techniques, 1982; Menlo Park: Addison Wesley; 265-295.
V Collado-Seidel, et al., "A Controlled Study of Additional sr-L-dopa in L-dopa-Responsive Restless Legs Syndrome with Late-Night Symptoms," Neurology, 1999; 52:285-290.
CJ Earley, et al., "Pergolide and Carbidopa/Levodopa Treatment of the Restless Legs Syndrome and Periodic Leg Movements in Sleep in a Consecutive Series of Patients," Sleep 1996; 19(10):801-10.
KA Ekbom, "Restless Legs," Acta Medica Scandinavica, 1945; suppl. 158:1-123.
KA Ekbom, "Restless Legs Syndrome," Neurology, 1960; 10:868-873.
RG Fariello, "Pharmacodynamic and Pharmacokinetic Features of Carbergoline," Drugs, 1997; 55:S2, 10-16.
A Feigen, "Restless Legs Syndrome," JAMA, 1995; 274 (15) 1191-2.
B Frankel, "Restless Legs Syndrome," JAMA, 1974; 230:1302-1303.
LI Golbe, "Pregnancy and Movement Disorders," Neurologic Clinics, 1994; 12/3 (497-508).
C Gorman, et al., "Symptoms of Restless Legs," Arch Intern Med, 1965; 115:155-60.
C Guilleminault, et al., "Dopaminergic Treatment of Restless Legs and Rebound Phenomenon," Neurology, 1993; 43(2):445.
D Harriman, et al., "Ekbom's Syndrome and Burning Paraesthesiae," Brain, 1970; 93:393-406.
EM Heiman, et al., "Lithium-aggravated Nocturnal Myoclonus and Restless Legs Syndrome [letter]," American Journal of Psychiatry, 1986; 143:1191-1192.
F Heinze, et al., "Restless Legs and Orthostatic Hypotension in Primary Amyloidosis," Arch Neurol, 1967; 16:497-500.
W Hening, et al., "The Cortical Premovement Potentials in RLS Jerks," Sleep Res, 1991; 20:255.
WA Hening, et. al., "Dyskinesias while awake and periodic movements in Sleep in Restless Legs Syndrome: Treatment with Opioids," Neurology; 1986; 36:1363-1366.
S Iannaccone, et al., "Evidence of Peripheral Axonal Neuropathy in Primary Restless Legs Syndrome," Movement Disorders, 1995; 10:2-9.
S Jorgensen, et al., "Restless Legs Syndrome,"--Abstract, Ugeskrift for Laeger, 1989; 151 (11) 670-1.
PW Kaplan, et al., "A Double-Blind, Placebo-Controlled Study of the Treatment of Periodic Limb Movements in Sleep using Carbidopal/Levodopa and Propoxyphene," Sleep, 1993; 16 (8) 717-23.
S Kotagal, et al., "Nocturnal Myoclonus--A Sleep Disturbance in Children with Leukemia," Annals of Neurology, 1984; 16:392.
E Lugaresi, et al., "Nocturnal Myoclonus and Restless Legs Syndrome," In: S Fahn et al. (eds), Advances in Neurology, 1986; vol. 43: Myoclonus, New York: Raven Press; 295-307.
MW Mahowald, et al., "Parasomnias Including in the Restless Legs Syndrome," Clinics in Chest Medicine, 1998; 19/1 (183-202).
P Martinelli, et al., "Nocturnal Myoclonus, Restless Legs Syndrome, and Abnormal Electrophysiological Findings," Ann Neurol, 1987; 21:515.
WB Matthews, "Iron Deficiency and Restless Legs," Br Med J, 1976; 1-898.
M Miyagi, et al., "Dopamine Receptor Affinities in vitro and Steriotypic Activities in vivo of Cabergoline in Rats," Biol. Pharm. Bull., 1996; 19L 1210-1213.
H Moldofsky, et al., "Sleep-related Myoclonus in Rheumatic Pain Modulation Disorder (Fibrositis Syndrome) and in Excessive Daytime Somnolence," Psychosomatic Medicine, 1984; 46:145-151.
J Montplaisir, et al., "Familial Restless Legs with Periodic Movements in Sleep:Electrophysiological, Biochemical, and Pharmacological Study," Neurology, 1985; 35:130-134.
J Montplaisir, et. al., "Restless Legs Syndrome and Periodic Movements in Sleep: Physiopathology and Treatment with L-dopa," Clinical Neuropharmacology, 1986; 9:456-463.
J Montplaisir, et al., "The Effect of Pramipexole, A D3 Preferring Agonist, on the Restless Legs Syndrome (RLS)," Neurology, 1999; vol. 52; p. 938.
J Montplaisir, et al., "The Effect of Pramipexole on Sensory and Motor Manifestations of the Restless Leg Syndrome," American Academy of Neurology, Minneapolis Convention in Minnesota, Apr. 29, 1998.
J. Montplasir, et al., "The Treatment of the Restless Leg Syndrome With or Without Periodic Leg Movements in Sleep," Sleep, 1992; 15(5): 391-395.
SS Mosko, et al., "Somatosensory and Brainstem Auditory Evoked Responses in Sleep-related Periodic Leg Movements," Sleep, 1986; 9:399-404.
S Noel, et al., "Low Dosage of Pergolide in the Treatment of Restless Legs Syndrome," Acta Neurologica Belgica, 1998; 98 (1) 52-3.
M Oechsner, "[Idiopathic Restless Legs Syndrome: Combination Therapy with Levodopa and *** Ropinirole***]," Aktuelle Neurologie, 1998; 25/5 (190-192).
Ondo, W, "Ropinirole for Restless Legs Syndrome," Mov Disord., 1999; 1, pp. 138-140.
G Reynolds, et al., "Restless Leg Syndrome and Rheumatoid Arthritis," British medical Journal, 1986; 292:659-660.
E Ruiz-Primo, Is Nocturnal Myoclonus a Common Sleep Disturbance in Children with Leukaemia, Dev Med Child Neurol, 1987; 29:833.
F Salvi, et al., "Restless Legs Syndrome and Nocturnal Myclonus: Initial Clinical Manifestation of Familial Amyloid Polyneuropathy," J Neurol Neurosurg Psychiatry, 1990; 53:522-525.
R Sandyk, et al., "L-Dopa in Uremic Patients with the Restless Legs Syndrome," Int J Neurosci, 1987; 35:233-235.
MH Silber, et al., "Pergolide in the Management of Restless Legs Syndrome: An Extended Study," Sleep 1997; 20(10):878-82.
MH Silber, et al., "Restless Legs Syndrome," Mayo Clinic Proceedings, 1997; 72/3 (261-264).
JS Simpson, "Familial Akathisia and Depression Treated with Mefazodone [letter]," Canadian Journal of Psychiatry, Revue Canadienne De Psychiatre, 1996; 41 (8) 539-40.
JD Spillane, "Restless Legs Syndrome in Chronic Pulmonary Diseases," Br Med J, 1970; 4:796-798.
J Staedt, et al., "Nightly Myoclonus Syndrome (NMS) and Restless Legs Syndrome (RLS)--Review and Case Report," Fortschr. Neurol. Psychiat. 62, 1994; pp. 88-93.
J Staedt, et al, "Pergolide: Treatment of Choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Long Term Follow up on Pergolide. Short Communication," Journal of Neural Transmission, 1998; 105 (2-3) 265-8.
J Staedt, et al., "Pergolide: Treatment of Choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). A Double-Blind Randomized Crossover Trial of Pergolide versus L-Dopa," Journal of Neural Transmission, 1997; 104 (4-5) 461-8.
K Stiasny, et al., "Cabergoline in RLS," ENS, Nice Abstract, 1998.
MJ Thorpy, Chairman, Diagnostic Classification Steering Committee in International Classification of Sleep Disorders: Diagnostic and Coding Manual--Table of Contents, 1990; American Sleep Disorders Association.
C Trenkwalder, et al., "L-Dopa in Uremic and Idiopathic Restless Legs Syndrome: a double-blind, crossov
Gomez-Mancilla Baltazar
Meier Dieter
Montplaisir Jacques
Oertel Wolfgang H.
Pharmacia & Upjohn Company
Spivack Phyllis G.
Wootton Thomas A.
LandOfFree
Use of pramipexole in the treatment of restless legs syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pramipexole in the treatment of restless legs syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pramipexole in the treatment of restless legs syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863842